Sudarshan Pharma Industries Ltd — Important, 14-08-2026: Company Update

SUDARSHAN PHARMA INDUSTRIES LTD has announced an FCCB Committee meeting on Wednesday, 19th August, 2026. The committee will review and potentially approve converting a portion of its Foreign Currency Convertible Bond (FCCB) funds into new equity shares for allotment. This move could alter the company's capital structure, potentially leading to equity dilution for current shareholders while simultaneously reducing debt and boosting equity on the balance sheet. Investors should watch for updates on this potential conversion.